Viewing data from:

BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE

ANDA

BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE | A217511 | INGENUS PHARMACEUTICALS LLC

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: PYLERA(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 1 NDC

Highest NADAC/Unit

$2.39

per ea

Lowest NADAC/Unit

$2.39

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
50742028313BISMUTH-METRONIDAZOLE-TETRACYCLINE 140-125-125 MG CAPSULE	$2.39	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain0 active DMFs1 inactive

0 active API suppliers hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

OMICRON QUIMICA SAInactiveBISMUTH SUBCITRATE

DMF 127231997

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 140MG;125MG;125MG

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Jul 3, 2023

No patent or exclusivity listings for this strength.